Process For Preparing SHP2 Inhibitors

US2025034160A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025034160-A1
Application numberUS-202418895975-A
CountryUS
Kind codeA1
Filing dateSep 25, 2024
Priority dateMar 28, 2022
Publication dateJan 30, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are methods for preparing a SHP2 inhibitor and intermediates useful therein.

First claim

Opening claim text (preview).

1 . A method of preparing a compound of Formula (7): comprising: reacting a compound of Formula (6): with a reducing agent to form the compound of Formula (7). 2 . The method of claim 1 , wherein the reducing agent is an organoaluminum hydride, an aluminum hydride, an organoborane hydride, or a borohydride reagent. 3 . The method of claim 1 or 2 , wherein the reaction is carried out using an alcohol, an aprotic solvent, or a mixture thereof as solvent. 4 . A method of preparing a compound of Formula (6): comprising reacting a compound of Formula (5): wherein R 2 is C 1 -C 6 alkyl, and TBDMS is tert-butyldimethylsilyl ether, with a deprotecting agent to form the compound of Formula (6). 5 . The method of any one of claims 1-4 , wherein the compound of Formula (6) is prepared by reacting a compound of Formula (5): wherein R 2 is C 1 -C 6 alkyl, and TBDMS is tert-butyldimethylsilyl ether, with a deprotecting agent to form the compound of Formula (6). 6 . The method of claim 4 or 5 , wherein the deprotecting agent is a source of fluoride ion, acetyl chloride, N-iodosuccinimide, HCl, acetic acid, formic acid, phosphoric acid, FeCl 3 , AlCl 3 , CeCl 3 , oxalyl chloride, isobutyl chloroformate, ethyl chloroformate, or thionyl chloride. 7 . The method of any one of claims 4-6 , wherein the reaction of the compound of Formula (5) with the deprotecting agent is carried out using an aprotic solvent. 8 . The method of any one of claims 4-7 , wherein the compound of Formula (5) is prepared by reacting a compound of Formula (3): with a compound of Formula (4): wherein R 2 is C 1 -C 6 alkyl, to form the compound of Formula (5). 9 . The method of claim 8 , wherein the reaction of the compound of Formula (3) with the compound of Formula (4) further comprises a base. 10 . The method of claim 8 or 9 , wherein the reaction of the compound of Formula (3) with the compound of Formula (4) is carried out using an aprotic solvent. 11 . The method of any one of claims 8-10 , wherein the compound of Formula (3) is prepared by reacting a compound of Formula (2): wherein R 1 is C 1 -C 6 alkyl, with a reducing agent to form the compound of Formula (3). 12 . The method of claim 11 , wherein the reducing agent used for the reaction of the compound of Formula (2) is an organoaluminum hydride, an aluminum hydride, an organoborane hydride, or a borohydride reagent. 13 . The method of claim 11 or 12 , wherein the reaction of the compound of Formula (2) with the reducing agent is carried out using an aprotic solvent. 14 . The method of any one of claims 11-13 , wherein the compound of Formula (2) is prepared by reacting a compound of Formula (1): wherein R 1 is C 1 -C 6 alkyl, with TBDMS-X, wherein X is a halide, to form the compound of Formula (2). 15 . The method of claim 14 , wherein the reaction of the compound of Formula (1) with TBDMS-X further comprises a base. 16 . The method of claim 14 or 15 , wherein the reaction of the compound of Formula (1) with TBDMS-X is carried out using an aprotic solvent. 17 . A method of preparing a compound of Formula (8): comprising reacting the compound of Formula (7) prepared according to the method of any one of claims 1 - 16 with a sulfonyl chloride or an acid chloride, and a base to form the compound of Formula (8). 18 . The method of claim 17 , wherein the sulfonyl chloride or the acid chloride is an arylsulfonyl chloride, an alkylsulfonyl chloride, or an aryl acid chloride. 19 . The method of claim 17 or 18 , wherein the reaction of Formula (7) with the sulfonyl chloride or the acid chloride and the base is carried out using a mixture of water and an aprotic solvent. 20 . A method of preparing a compound of Formula (9): comprising reacting the compound of Formula (8) prepared according to the method of any one of claims 17 - 19 with an oxidizing agent to form the compound of Formula (9). 21 . The method of claim 20 , wherein the oxidizing agent is Dess-Martin periodinane, (2,2,6,6-tetramethylpiperidine-1-yl)oxyl (TEMPO), or sulfur trioxide pyridine complex. 22 . The method of claim 21 , wherein the reaction of the compound of Formula (8) with TEMPO further comprises (diacetoxyiodo)benzene or sodium hypochlorite, and optionally further comprises a salt. 23 . The method of any one of claims 20-22 , wherein the reaction of the compound of Formula (8) with the oxidizing agent is carried out using an aprotic solvent or a mixture of an aprotic solvent and water. 24 . A method of preparing a compound of Formula (10) or a salt thereof: comprising reacting the compound of Formula (9) prepared according to the method of any one of claims 20 - 23 with an acid to form the compound of Formula (10) or a salt thereof. 25 . A method of preparing a compound of Formula (10)⋅HCl comprising the following steps: wherein R 1 and R 2 are each independently methyl or ethyl. 26 . The method of any one of claims 20-25 , wherein the compound of Formula (9) and/or the compound of Formula (10), or a salt thereof, are prepared without use of column chromatography. 27 . A method of preparing a compound of Formula (11): or a salt thereof, comprising converting the compound of Formula (10), or a salt thereof, prepared according to any one of claims 24 - 26 to the compound of Formula (11) or a salt thereof. 28 . A compound of Formula (6):

Assignees

Inventors

Classifications

  • Unsubstituted amino or imino radicals · CPC title

  • by oxygen atoms · CPC title

  • with only one oxygen atom as ring hetero atom in the oxygen-containing ring · CPC title

  • Spiro-condensed systems · CPC title

  • C07D211/20Primary

    with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025034160A1 cover?
Provided herein are methods for preparing a SHP2 inhibitor and intermediates useful therein.
Who is the assignee on this patent?
Genzyme Corp
What technology area does this patent fall under?
Primary CPC classification C07D491/107. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).